|
Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways Journal Article published Jul 2020 in Journal of the American Academy of Dermatology volume 83 issue 1 on pages 63 to 70 Research funded by Sun Pharma | AbbVie | UCB | Pfizer | Boehringer Ingelheim | Celgene | Galderma | AstraZeneca | Novartis | Novartis | Amgen | Regeneron Pharmaceuticals | Dermira | Janssen Biotech | MedImmune | Eli Lilly and Company | Anacor Pharmaceuticals, Inc | Kadmon Corporation, LLC | LEO Pharma | MedImmune, LLC | Valeant Pharmaceuticals | Eli Lilly | Janssen | Vitae | Glenmark | Asana | Innovaderm |
|
Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000–2018 Journal Article published Sep 2021 in Clinical Microbiology and Infection volume 27 issue 9 on pages 1301 to 1307 Research funded by MSD France | Agence Nationale de Recherches sur le Sida et les Hépatites Virales | Gilead Sciences | Janssen Biotech | Centre Hospitalier Universitaire de Bordeaux |
|
P-224 Expression of major components of the exosome biogenesis pathway is deregulated in colorectal cancer and associated with clinical outcome: Preliminary results from an association study Journal Article published Jul 2021 in Annals of Oncology volume 32 on pages S175 to S176 Research funded by Roche | Eli Lilly and Company | Janssen Biotech | Bayer | Meso Scale Diagnostics | Amgen | Genesis Pharma | Bristol-Myers Squibb | Merck |
|
DUAL expectations in light chain amyloidosis Journal Article published Jul 2020 in EClinicalMedicine volume 24 on page 100461 Research funded by Janssen Biotech |
|
Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection Journal Article published Jan 2021 in EClinicalMedicine volume 31 on page 100677 Research funded by Gilead Sciences | Janssen Biotech | Merck |
|
Lost in translation: Why ‘lost to follow-up’ matters Journal Article published Aug 2019 in Vascular Medicine volume 24 issue 4 on pages 339 to 340 Research funded by Bayer | Janssen Biotech | Amgen | Merck |
|
High-Dose Infliximab Therapy in Crohn’s Disease: Clinical Experience, Safety, and Efficacy Journal Article published 1 Mar 2015 in Journal of Crohn's and Colitis volume 9 issue 3 on pages 266 to 275 Research funded by Crohn's and Colitis Foundation of America (3830) | AbbVie | AstraZeneca | Amgen | MedImmune | Janssen Biotech | Pfizer | Millennium Pharmaceuticals | Takeda and Osiris | Prometheus Laboratories |
|
Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report Journal Article published Jan 2021 in Clinical Lymphoma Myeloma and Leukemia volume 21 issue 1 on pages e21 to e24 Research funded by Sanofi | Bristol-Myers Squibb | Celgene | Amgen | Novartis | AbbVie | Janssen Biotech |
|
Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis Journal Article published Sep 2020 in Clinics and Research in Hepatology and Gastroenterology volume 44 issue 4 on pages 524 to 531 Research funded by Agence Nationale de Recherches sur le Sida et les Hépatites Virales | Gilead Sciences | AbbVie | Janssen Biotech |
|
Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up Journal Article published Feb 2021 in Blood Cancer Journal volume 11 issue 2 Research funded by Celgene | Amgen | Bristol-Myers Squibb | Janssen Biotech |